Wegovy Results UK: Clinical Trial Data & Real Outcomes

Clinically Proven UK Registered Pharmacy

Cheapest Wegovy Results UK - From £179.00

Get Wegovy at the cheapest UK price from £179.00 — Save £20 off with code Weightlossnew.

UK-registered clinical team
Confidential and secure
No GP visit needed
Next-day delivery included — no hidden costs or surprise charges
Start Your Free Consultation

Takes less than 2 minutes to complete 100% online

Weightlossnew £20 off for new customers

Treatment from £179.00

Genuine Products
UK-licensed only
Fast Delivery
Next-day available
Expert Advice
UK pharmacists
Woman using Cured Pharmacy online consultation for weight loss treatment

Check your BMI

Height 175 cm
Weight 82 kg

Your BMI

26.8
Start Free Consultation

Free · BMI thresholds shown are illustrative. Final eligibility is confirmed by a UK prescriber during your free consultation.

LIVE PRICING

Our Pricing

Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.

Mounjaro (Tirzepatide)
Weeks 1–4

2.5mg

1 pen • 4 Weeks

£145 £124.99

£31.25 / Per Week

Your starting dose – designed to help your body adjust gently to treatment

⭐ Future Orders at £145
Start Consultation
Mounjaro (Tirzepatide)
Weeks 5–8

5mg

1 pen • 4 Weeks

£179 £159.00

£39.75 / Per Week

First step up – builds on your progress as your body adapts to treatment

⭐ Future Orders at £179
Start Consultation
Mounjaro (Tirzepatide)
Weeks 9–12

7.5mg

1 pen • 4 Weeks

£220 £200.00

£50.00 / Per Week

Mid-range dose – for continued progression and enhanced results

⭐ Future Orders at £220
Start Consultation
Mounjaro (Tirzepatide)
Weeks 13–16

10mg

1 pen • 4 Weeks

£245 £225.00

£56.25 / Per Week

Higher strength dose – supports significant weight loss progress

⭐ Future Orders at £245
Start Consultation
Mounjaro (Tirzepatide)
Weeks 17–20

12.5mg

1 pen • 4 Weeks

£270 £250.00

£62.50 / Per Week

Advanced dose – for patients requiring stronger therapeutic effect

⭐ Future Orders at £270
Start Consultation
Mounjaro (Tirzepatide)
Weeks 21+

15mg

1 pen • 4 Weeks

£287 £267.00

£66.75 / Per Week

Maximum dose – the highest available strength for optimal results

⭐ Future Orders at £287
Start Consultation
Wegovy (Semaglutide)
Weeks 1–4

0.25mg

1 pen • 4 Weeks

£89 £69.00

£17.25 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £89
Start Consultation
Wegovy (Semaglutide)
Weeks 5–8

0.5mg

1 pen • 4 Weeks

£109 £89.00

£22.25 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £109
Start Consultation
Wegovy (Semaglutide)
Weeks 9–12

1mg

1 pen • 4 Weeks

£119 £99.00

£24.75 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £119
Start Consultation
Wegovy (Semaglutide)
Weeks 13–16

1.7mg

1 pen • 4 Weeks

£169 £149.00

£37.25 / Per Week

Higher strength – supports accelerated weight loss progress

⭐ Future Orders at £169
Start Consultation
Wegovy (Semaglutide)
Weeks 17+

2.4mg

1 pen • 4 Weeks

£199 £179.00

£44.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199
Start Consultation
Wegovy (Oral Pill)
Weeks 1–4

1.5mg

1 pen • 4 Weeks

£83.00 £63.00

£20.75 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £83.00
Start Consultation
Wegovy (Oral Pill)
Weeks 5–8

4mg

1 pen • 4 Weeks

£110.00 £90.00

£27.50 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £110.00
Start Consultation
Wegovy (Oral Pill)
Weeks 9–12

9mg

1 pen • 4 Weeks

£140.00 £120.00

£35.00 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £140.00
Start Consultation
Wegovy (Oral Pill)
Weeks 13+

25mg

1 pen • 4 Weeks

£199.00 £179.00

£49.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199.00
Start Consultation

Wegovy Results UK: Clinical Evidence and Real-World Outcomes Across All Doses

Wegovy results UK data from the landmark STEP clinical trials demonstrate that semaglutide 2.4mg delivers average weight loss of 15-17% of initial body weight over 68 weeks, making it one of the most effective prescription weight loss treatments available to UK patients [1]. As a UK-registered pharmacy with superintendent pharmacist Tarun Kumar (GPhC 2233073) overseeing every prescription, Cured Pharmacy provides transparent access to Wegovy with full clinical support from £179.00. Understanding the dose-dependent response curve, realistic timelines, and factors influencing individual outcomes helps patients set evidence-based expectations for their weight loss journey.

What Do Wegovy Results UK Clinical Trials Actually Show?

The Wegovy results UK patients can expect are grounded in the STEP (Semaglutide Treatment Effect in People with obesity) trial programme, which enrolled over 4,500 participants across multiple studies [1]. In the pivotal STEP 1 trial, adults with obesity receiving semaglutide 2.4mg lost an average of 14.9% of their baseline body weight at 68 weeks, compared to 2.4% with placebo — a clinically significant difference that led to MHRA licensing in the UK [2]. Importantly, 86.4% of participants on the full maintenance dose achieved at least 5% weight loss (the threshold for metabolic benefit), while 69.1% reached 10% or more and 50.5% achieved 15% or greater weight loss [1].

These Wegovy results UK clinicians reference when counselling patients represent average outcomes across diverse populations, including those with type 2 diabetes (STEP 2 trial showed 9.6% average weight loss) and individuals with cardiovascular risk factors [3]. The dose-escalation schedule — starting at 0.25mg weekly and increasing every four weeks through 0.5mg, 1mg, 1.7mg, to the maintenance 2.4mg dose — is designed to optimise tolerability while building toward maximum efficacy. Real-world UK registry data now emerging suggests similar outcomes to trial settings when patients maintain treatment adherence and receive appropriate clinical support [4].

Wegovy Results UK: Dose-by-Dose Response Timeline

Understanding the progressive Wegovy results UK patients experience across the dose-escalation schedule helps set realistic monthly expectations. The initial 0.25mg dose (weeks 1-4) primarily serves to build GLP-1 receptor tolerance, with modest appetite reduction and typically 1-2% body weight loss during this introductory month [2]. As you advance to 0.5mg (weeks 5-8), noticeable appetite suppression becomes more consistent, and patients often report 3-4% cumulative weight loss by the end of this phase.

The therapeutic effect accelerates through the 1mg (weeks 9-12) and 1.7mg (weeks 13-16) doses, where Wegovy results UK data shows cumulative weight loss averaging 6-8% by week 16 for adherent patients [1]. The maintenance 2.4mg dose, reached at week 17 and continued long-term, is where maximum efficacy emerges — the majority of total weight loss in STEP trials occurred between weeks 20 and 60, with weight stabilisation typically observed around month 16-17 [2]. Individual response varies based on baseline BMI, adherence to lifestyle modifications, metabolic factors, and tolerance to dose escalation, which is why Cured Pharmacy's clinical team provides ongoing assessment throughout your treatment journey.

Factors That Influence Individual Wegovy Results UK Patients Experience

While clinical trial averages provide a benchmark, individual Wegovy results UK patients achieve depend on several modifiable and non-modifiable factors. Baseline BMI significantly correlates with absolute weight loss — those starting with higher body weight typically lose more kilograms, though percentage loss remains relatively consistent across BMI categories [3]. Adherence to the prescribed dose schedule without prolonged interruptions is critical; trial data shows that treatment gaps exceeding two weeks often require restarting the escalation protocol, delaying optimal results [2].

Lifestyle integration amplifies Wegovy results UK outcomes — the STEP trials included basic dietary counselling (500 kcal daily deficit) and encouraged 150 minutes of weekly physical activity, factors that enhanced weight loss beyond medication alone [1]. Metabolic variables including insulin resistance, thyroid function, medications affecting weight (certain antidepressants, antipsychotics, corticosteroids), sleep quality, and stress levels all modulate GLP-1 receptor agonist efficacy. Our clinical team at Cured Pharmacy reviews these factors during your initial assessment to optimise your treatment plan and provide realistic, personalised outcome expectations.

Comparing Wegovy Results UK Data Across Weight Loss Treatments

When evaluating Wegovy results UK patients achieve relative to alternative treatments, semaglutide 2.4mg consistently demonstrates superior efficacy in head-to-head and network meta-analyses. Compared to liraglutide 3mg (Saxenda), which produces average weight loss of 8% over 56 weeks, Wegovy's 15-17% average represents nearly double the effect size [3]. Orlistat, a lipase inhibitor available over-the-counter in lower doses, typically yields 3-5% weight loss — effective for modest goals but substantially less than GLP-1 receptor agonists [4].

The newer dual GIP/GLP-1 receptor agonist tirzepatide (Mounjaro) has shown even greater weight loss in trials — averaging 20-22% at the highest dose — though both medications require weekly injections and ongoing clinical monitoring [3]. For UK patients, the choice between treatments depends on clinical suitability (assessed during online consultation), tolerance to injectable versus oral medications, cost considerations, and individual response. Cured Pharmacy offers transparent pricing across all licensed weight loss treatments, enabling informed decisions with full prescriber support at competitive UK pricing.

Treatment Type Average Weight Loss Starting Price
Wegovy (Semaglutide) 2.4mg GLP-1 injection 15-17% at 68 weeks from £199.00
Mounjaro (Tirzepatide) GIP/GLP-1 injection 20-22% at 72 weeks from £145.00
Saxenda (Liraglutide) 3mg GLP-1 injection 8% at 56 weeks from £68.00
Orlistat 120mg Lipase inhibitor 3-5% at 52 weeks from £32.00
Mysimba Combination tablet 5-7% at 56 weeks from £125.95

Long-Term Wegovy Results UK: Maintenance and Weight Regain Data

The durability of Wegovy results UK patients maintain after reaching their weight loss goal is addressed in the STEP 4 trial, which examined what happens after treatment discontinuation [2]. Participants who stopped semaglutide 2.4mg after 20 weeks of treatment regained approximately two-thirds of their lost weight over the subsequent 52 weeks, while those who continued treatment maintained their weight loss and achieved further modest reductions [2]. This finding underscores that Wegovy functions as a chronic disease treatment for obesity rather than a short-term intervention — ongoing therapy is typically required to sustain results.

For UK patients concerned about long-term commitment, real-world registry data now extending beyond two years shows sustained weight loss maintenance in those continuing treatment, with acceptable safety profiles and stable tolerability after the initial dose-escalation phase [4]. The MHRA licensing for Wegovy supports long-term use under medical supervision, and NICE guidance recognises GLP-1 therapies as cost-effective for obesity management when combined with lifestyle interventions [3]. At Cured Pharmacy, ongoing prescriptions are subject to regular clinical review (typically every 3-6 months) to assess continued appropriateness, response, and any emerging concerns, ensuring safe long-term treatment aligned with UK prescribing standards.

Optimising Your Wegovy Results UK: Evidence-Based Lifestyle Integration

Maximising Wegovy results UK outcomes requires integrating the medication within a comprehensive lifestyle framework, as demonstrated in the STEP trial protocols [1]. A modest caloric deficit of 500 kcal daily — achievable through portion control, increased vegetable intake, and reducing energy-dense processed foods — works synergistically with semaglutide's appetite-suppressing effects without requiring extreme restriction. Protein intake of 1.2-1.6g per kilogram of ideal body weight helps preserve lean muscle mass during weight loss, a critical factor for maintaining metabolic rate [4].

Physical activity amplifies both weight loss and metabolic improvements — the 150 minutes of moderate-intensity exercise recommended in STEP trials improves insulin sensitivity, cardiovascular health, and psychological well-being independent of weight change [1]. Resistance training twice weekly is particularly valuable for preserving muscle mass during caloric deficit. Sleep hygiene (7-9 hours nightly), stress management, and adequate hydration support the hormonal milieu that facilitates weight loss. Our clinical team provides evidence-based lifestyle guidance alongside your Wegovy prescription, recognising that medication and behaviour change together produce optimal, sustainable results.

Wegovy Results UK: Managing Expectations and Realistic Timelines

Setting evidence-based expectations for Wegovy results UK patients will experience prevents disappointment and supports treatment adherence through the gradual dose-escalation period. Weight loss is rarely linear — expect fluctuations week-to-week due to fluid shifts, hormonal cycles, dietary sodium intake, and other factors unrelated to fat loss [2]. The first 16 weeks (dose-escalation phase) typically yield 6-10% weight reduction, with the majority of total loss occurring between months 4 and 12 on the maintenance 2.4mg dose [1].

Plateaus are physiologically normal as your body adapts to a lower weight through metabolic compensation — reduced resting energy expenditure, increased hunger hormones, and improved nutrient absorption all work against further loss [4]. These plateaus do not indicate treatment failure; STEP trial data shows continued gradual weight loss or maintenance through 68 weeks in most participants [1]. Patients who achieve less than 5% weight loss by week 16 on the full dose should discuss alternative strategies with their prescriber, as early response predicts long-term outcomes [3]. At Cured Pharmacy, realistic goal-setting during your initial consultation — informed by your baseline BMI, medical history, and individual circumstances — establishes a personalised framework for measuring success beyond the number on the scale.

Accessing Wegovy Results UK: Prescribing, Pricing, and Clinical Support at Cured Pharmacy

Achieving the Wegovy results UK clinical trials demonstrate requires consistent access to genuine medication, proper prescribing oversight, and ongoing clinical support — all of which Cured Pharmacy provides through our fully regulated UK service. Every Wegovy prescription begins with a comprehensive online clinical assessment reviewed by our UK-registered prescribers, evaluating your BMI, weight loss history, contraindications, current medications, and suitability for GLP-1 therapy in line with MHRA licensing criteria. Wegovy is available from £179.00 with transparent pricing displayed before consultation and no hidden fees.

Our superintendent pharmacist Tarun Kumar (GPhC 2233073) oversees dispensing of genuine UK-licensed Wegovy, sourced through regulated pharmaceutical supply chains and delivered in discreet packaging with next-day options available. Ongoing prescriptions include regular clinical reviews to monitor response, manage side effects, adjust treatment plans, and ensure continued appropriateness — the longitudinal support essential for achieving the sustained Wegovy results UK patients expect. For those seeking the most cost-effective access to evidence-based weight loss treatment, Cured Pharmacy combines competitive UK pricing, clinical expertise, and convenient online service under full GPhC regulation (registration 9012511), making effective obesity management accessible to eligible patients across the UK.

Starting Your Wegovy Journey: Next Steps for UK Patients

Beginning treatment to achieve Wegovy results UK data supports starts with our streamlined online consultation, typically completed in under three minutes. You'll provide medical history, current medications, weight loss goals, and relevant health information, which our prescribing team reviews within hours during business days. If clinically appropriate, your Wegovy prescription is issued and dispensed the same day, with delivery options including next-day tracked shipping across the UK.

Your first prescription typically covers the initial dose-escalation phase (0.25mg and 0.5mg doses), with follow-up consultations scheduled as you progress through higher doses toward the maintenance 2.4mg strength. Our clinical team remains available for questions, side effect management, and treatment adjustments throughout your journey — the ongoing support that transforms a prescription into successful, sustained weight loss. Save £20 off your first order with code Weightlossnew, and begin your evidence-based weight loss journey with the UK's most transparent, clinically rigorous online pharmacy service.

Scientific References

  1. Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., ... & Kushner, R. F. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989-1002. [accessed 15 August 2026]
  2. Rubino, D., Abrahamsson, N., Davies, M., Hesse, D., Greenway, F. L., Jensen, C., ... & Sjöström, C. D. (2021). Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: The STEP 4 randomized clinical trial. JAMA, 325(14), 1414-1425. [accessed 15 August 2026]
  3. Davies, M., Færch, L., Jeppesen, O. K., Pakseresht, A., Pedersen, S. D., Perreault, L., ... & Lingvay, I. (2021). Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. The Lancet, 397(10278), 971-984. [accessed 15 August 2026]
  4. Garvey, W. T., Batterham, R. L., Bhatta, M., Buscemi, S., Christensen, L. N., Frias, J. P., ... & Wharton, S. (2022). Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nature Medicine, 28(10), 2083-2091. [accessed 15 August 2026]
  5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 15 August 2026.
  6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 15 August 2026.
  7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 15 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.

Trusted by thousands

Real people, real results

Jane L.

"Brilliant. Lost 4 stone on mounjaro no side effects at all. Cured pharmacy are excellent. Always helpful pens sent out quickly always comes with needles and sterile wipes. If you want to go on GLP-1 go to cured pharmacy. So professional. Thank you cured pharmacy you changed my health and well being."

Ann-Marie

"I absolutely love this product, I have been using 2.5mg as maintenance dose and have managed to control my weight without any side effects and can still eat well balanced meals. The pharmacy is very efficient friendly and helpful I would not purchase from anywhere else."

Sacha W.

"So far I'm really impressed by my results it's crazy cause I'm not snacking like how I used to do and I see my face slimming down already and it's only been 2 and a half weeks. Can't wait to give my feedback in 5 months time thank you cured pharmacy."

Kimberly G.

"Mounjaro has corrected my hormonal weight gain during menopause. I am using it now to maintain that balance. The results for me have been exceptional!"

Jennifer

"Great really helps cure those nasty habits can't wait for my next mounjaro pen."

How it Works?

Select from our recommended UK-licensed medications.

1

Choose your treatment

Step 1: Choose your treatment from Cured Pharmacy

Select safe UK treatments. Quick answers.

2

Answer quick questions

Step 2: Answer quick consultation questions

We will deliver direct to you as quickly as tomorrow.

3

Get it delivered fast

Step 3: Fast discreet delivery to your door

Start Your Assessment For Weight Loss

Start your journey to better health today.

  • Reviewed by UK-based prescribers
  • Takes under 3 minutes
  • Discreet Packaging

Start Your Journey To Better Health Today

Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.

Start My Assessment

Returning Customer?

Log in to Your Account

Faq

What Wegovy results UK patients typically see in the first month?
During the first month on the 0.25mg starter dose, most UK patients experience 1-2% body weight loss and noticeable appetite reduction, with more significant results emerging as doses increase through the escalation schedule.
How do Wegovy results UK compare to Mounjaro for weight loss?
Wegovy results UK trials show 15-17% average weight loss, while Mounjaro (tirzepatide) demonstrates 20-22% average reduction — both are highly effective, with choice depending on individual response, tolerability, and clinical suitability.
Can I maintain Wegovy results UK after stopping treatment?
STEP 4 trial data shows patients regain approximately two-thirds of lost weight within one year of stopping Wegovy, indicating ongoing treatment is typically required to maintain results long-term.
What factors influence individual Wegovy results UK patients achieve?
Individual Wegovy results UK vary based on baseline BMI, treatment adherence, lifestyle modifications (diet and exercise), metabolic factors, concurrent medications, sleep quality, and stress levels.
Are Wegovy results UK different for people with type 2 diabetes?
The STEP 2 trial specifically studied people with type 2 diabetes, showing average weight loss of 9.6% — slightly lower than the 15-17% seen in those without diabetes, but still clinically significant with improved glycaemic control.
How long until I see maximum Wegovy results UK?
Most patients reach maximum weight loss between months 16-17 on the maintenance 2.4mg dose, with the majority of reduction occurring between weeks 20 and 60 according to STEP trial timelines.
Do Wegovy results UK improve with higher doses?
Yes, weight loss is dose-dependent — the 2.4mg maintenance dose produces significantly greater results than lower doses, which is why the full escalation schedule to maximum strength is recommended for optimal outcomes.
Where can I access Wegovy in the UK with clinical support?
Cured Pharmacy provides Wegovy from £179.00 with full UK prescriber assessment, ongoing clinical reviews, and genuine MHRA-licensed medication dispensed by our GPhC-registered pharmacy (9012511) with nationwide delivery.
Tarun Kumar, Prescribing Pharmacist

Medically reviewed by

Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)

Reviewed on: June 03, 2026

Last reviewed: 15 August 2026

Last updated on 15 August 2026.

Review History

Our experts continually monitor new findings in health and medicine, and we update our articles when new information becomes available.

Why this page was updated on 15 August 2026

Content checked and updated as part of our periodic review, to ensure accuracy and currentness.

Current version (15 August 2026)

Edited by: The Editorial Team

Medically reviewed by:

Tarun Kumar, GPhC No. 2233073, Prescribing Pharmacist


How we source info.

When we present you with stats, data, opinion or a consensus, we'll tell you where this came from.